Decídetexto

Feasibility and Acceptability of a Mobile Smoking Cessation Intervention in Puerto Rico

Bibliographic Data

ID15466108
AuthorsFrancisco Cartujano‐Barrera (0000-0001-8069-1750, University of Rochester Medicine, corresponding author), Cristina Peña-Vargas (0000-0003-3495-5991, Ponce Health Sciences University), Evelyn Arana‐Chicas (0000-0001-8666-6468, University of Rochester Medicine), José G Pérez-Ramos (0000-0002-6654-6984, University of Rochester Medicine), Josiemer Mattei (0000-0001-5424-8245, Harvard University), Alejandra Hurtado‐de‐Mendoza (0000-0003-1086-8869, Georgetown University), Rosario Costas-Muñíz (0000-0003-0942-5657, Memorial Sloan Kettering Cancer Center), Julio Jimenez (0000-0003-2860-145X, Ponce Health Sciences University), Ana Paula Cupertino (0000-0002-1423-7063, University of Rochester Medicine), Ana Cupertino (James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA), Eida Castro (0000-0003-3889-9114, Ponce Health Sciences University)
Year2021
Volume18
Issue4
Pages1379-1379
Publication date2021-02-03
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph18041379
PMID33546156
OpenAlexW3127243970
LanguagePT
Citations received4
References cited37

The purpose of this pilot study was to assess the feasibility and acceptability of a mobile smoking cessation intervention in Puerto Rico. This was a single-arm pilot study with 26 smokers in Puerto Rico who were enrolled in Decídetexto, a mobile smoking cessation intervention. Decídetexto incorporates three integrated components: (1) a tablet-based software that collects smoking-related information to develop an individualized quit plan, (2) a 24-week text messaging counseling program with interactive capabilities, and (3) pharmacotherapy support. Outcome measures included self-reported 7-day point prevalence abstinence at Months 3 and 6, pharmacotherapy adherence, satisfaction with the intervention, and changes in self-efficacy. The average age of the participants was 46.8 years (SD 12.7), half of them (53.8%) were female. Most participants (92.3%) smoked daily and half of them (53.8%) used menthol cigarettes. All participants requested nicotine patches at baseline. However, only 13.0% of participants used the patch >75% of days. At Month 3, 10 participants (38.4%) self-reported 7-day point prevalence abstinence (88.5% follow-up rate). At Month 6, 16 participants (61.5%) self-reported 7-day point prevalence abstinence (76.9% follow-up rate). Most participants (90%, 18/20) reported being satisfied/extremely satisfied with the intervention at Month 6. Self-efficacy mean scores significantly increased from 40.4 (SD 12.1) at baseline to 57.9 (SD 11.3) at Month 3 ( p < 0.01). The study suggests that Decídetexto holds promise for further testing among Puerto Rican smokers

Abstinence · Intervention (counseling · Nicotine dependence · Pharmacotherapy · Physical therapy · Psychiatry · Smoking cessation · Behavioral Health and Interventions · Digital Mental Health Interventions · Medicine · Smoking Behavior and Cessation

Tools

Open DOIOpen Access